期刊文献+

血清胱抑素C在高血压肾病患者外周血中表达的临床意义 被引量:7

Clinical significance of serum cystatin C measured in peripheral blood of patients with hypertensive nephropathy
原文传递
导出
摘要 目的探讨血清胱抑素C(Cys-C)在高血压肾病患者外周血中检测的临床意义。方法 102例高血压患者根据尿微量白蛋白排泄率(UAER)分为三组即Ⅰ﹑Ⅱ﹑Ⅲ组。清晨空腹抽取静脉血3ml检测血Cys-C、2-MG、BUN、Cr的浓度。结果高血压肾病患者Ⅰ组Cys-C浓度(0.92±0.14)mg/L,高于对照组(0.79±0.26)mg/l,差异具有统计学意义(P>0.05),其它三项指标结果高于对照组,但与对照组相比差异不具有统计学意义。Ⅱ组和Ⅲ组患者四项指标均高于对照组,且差异具有统计学意义(P<0.01)。结论 Cys-C敏感性和特异性高于2-MG、BUN、Cr,是反映肾小球滤过率变化的理想的内源性标志物。 Objective To explore the clinical significance of serum Cys - C measured in the pa- tients with hypertensive nephropathy. Methods Totally 104 patients were divided into three groups which were I group(30), Ⅱ group(35) andⅢ group(37) according to the UAER level,fasting serum Cys -C ,2 -MG, BUN, Cr levels were measured as well as the normal control group(30). Results The Cys - c level of I group was (0. 92 ± 0. 14) mg/1 which was higher than the level of the normal control group which was (0. 79 ±0. 26 ) mg/1, the difference had statistic significance ( P 〈 0. 05 ), the levels of the other three indexes were higher than normal control group, but the difference had no statis- tic significance (P 〉 0.05 ). With the aggravation of the disease, Cys -C ,2 -MG, BUN and Cr levels increased in Ⅱand Ⅲ groups, which were significantly higher than those in normal control group ( P 〈 0. 01 ). Conclusions Cys - C is an ideal endogenous marker in the reflection of changes of glomerular filtration rate, whose sensitivity and specificity were higher than those of 2 - MG, BUN and Cr.
出处 《医药论坛杂志》 2011年第19期44-45,共2页 Journal of Medical Forum
关键词 高血压肾病 血清胱抑素C 外周血 Hypertensive nephropathy Serum cystatin C Peripheral blood
  • 相关文献

参考文献4

二级参考文献9

共引文献12

同被引文献50

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2唐荣(译),凌云(译),卢洪洲(审校).HIV/AIDS合并慢性肾病者的治疗指南(美国感染病学会推荐方案)——HIV相关肾病的筛选[J].中国艾滋病性病,2006,12(6):585-587. 被引量:10
  • 3王开森,尹秋霞,牛爱军,薛炼,胡成进.血清胱抑素C对高血压和糖尿病早期肾功能损伤的诊断价值[J].实用医药杂志,2007,24(1):11-12. 被引量:13
  • 4Bolignano D, Donato V,Coppolino G ,et al. Neuyrophil gelatinase asso-ciated lipocalin as a marker of kidney damage [J]. Am J Kidney Dis,2008,52(3) :595 -605.
  • 5Mishra J,Ma Q, Prada A,ei al. Identification ol neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemic rti-na] injury [J] . Am Soc Nephrol,2003 ,14( 10) :2534 - 3543.
  • 6Laura P, Stefno T, Daniela L, et al. Cystatin C and Estimates of renalfunction : Searching for a better measure of kidney function in diabeticpatients[ J]. Clin Chem,2007,55.3) :480 -488.
  • 7de Melo RO, Toledo JC, Souza DR, et al. Factors associated with im-paired urinary albuminuria and hypertension. Int [ J ]. Cardiol ,2009,15(23):836 -839.
  • 8薛志强,童俊容.慢性肾脏疾病和尿液NGAL的改变及其临床意义[J].屮国中西医结合肾病杂志,2011,11 (5 ):440 -441.
  • 9赵洪涛,韩桂芳,刘秀英.胃癌并发肾病综合征[J].山东医药,1994,34(9):15.
  • 10杨有业,张秀明.临床检验方法学评价[S].北京:人民卫生出版社,2008:48-51.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部